Diercke M - Search Results

1

Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019.

von Laer A, Eckmanns T, Zacher B, Pfennigwerth N, Gatermann SG, Reichert F, Diercke M, Steffen G, Altmann D, Reuss A. von Laer A, et al. Among authors: diercke m. Antimicrob Resist Infect Control. 2022 Feb 4;11(1):25. doi: 10.1186/s13756-021-01045-z. Antimicrob Resist Infect Control. 2022. PMID: 35120555 Free PMC article.

2

[The 2015 edition of case definitions for the surveillance of notifiable infectious diseases in Germany].

Diercke M, Benzler J, Schöneberg I, Mücke I, Altmann D, Claus H, Gilsdorf A; Mitarbeiter der Abteilung für Infektionsepidemiologie. Diercke M, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Sep;57(9):1107-10. doi: 10.1007/s00103-014-2023-3. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014. PMID: 25096238 German.

3

Evaluation of the statutory surveillance system for invasive MRSA infections in Germany, 2016-2017.

Schönfeld V, Diercke M, Gilsdorf A, Eckmanns T, Walter J. Schönfeld V, et al. Among authors: diercke m. BMC Public Health. 2018 Aug 24;18(1):1063. doi: 10.1186/s12889-018-5971-y. BMC Public Health. 2018. PMID: 30143016 Free PMC article.

4

Evaluation of the German surveillance system for hepatitis B regarding timeliness, data quality, and simplicity, from 2005 to 2014.

Boes L, Houareau C, Altmann D, An der Heiden M, Bremer V, Diercke M, Dudareva S, Neumeyer-Gromen A, Zimmermann R. Boes L, et al. Among authors: diercke m. Public Health. 2020 Mar;180:141-148. doi: 10.1016/j.puhe.2019.11.012. Epub 2020 Jan 6. Public Health. 2020. PMID: 31918048

5

Implications of a change in case definition and screening of asylum seekers for hepatitis B surveillance in Germany in 2015 and 2016.

von Laer A, Diercke M, An der Heiden M, Altmann D, Zimmermann R, Dudareva S. von Laer A, et al. Among authors: diercke m. Epidemiol Infect. 2020 Feb 24;148:e36. doi: 10.1017/S0950268820000242. Epidemiol Infect. 2020. PMID: 32089143 Free PMC article.

6

[The different periods of COVID-19 in Germany: a descriptive analysis from January 2020 to February 2021].

Schilling J, Tolksdorf K, Marquis A, Faber M, Pfoch T, Buda S, Haas W, Schuler E, Altmann D, Grote U, Diercke M; RKI COVID-19 Study Group. Schilling J, et al. Among authors: diercke m. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Sep;64(9):1093-1106. doi: 10.1007/s00103-021-03394-x. Epub 2021 Aug 10. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021. PMID: 34374798 Free PMC article. German.

7

SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022.

Sievers C, Zacher B, Ullrich A, Huska M, Fuchs S, Buda S, Haas W, Diercke M, An der Heiden M, Kröger S. Sievers C, et al. Among authors: diercke m. Euro Surveill. 2022 Jun;27(22):2200396. doi: 10.2807/1560-7917.ES.2022.27.22.2200396. Euro Surveill. 2022. PMID: 35656831 Free PMC article.

8

[How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop].

Zimmermann R, Külper-Schiek W, Steffen G, Gillesberg Lassen S, Bremer V, Dudareva S; die Hepatitis-Monitoring-Arbeitsgruppe. Zimmermann R, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Jan;64(1):77-90. doi: 10.1007/s00103-020-03260-2. Epub 2020 Dec 16. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021. PMID: 33326051 Free PMC article. German.

9

COVID-19 -Analysis of Incident Cases Reported Within the German Healthcare System.

Kramer R, Klingeberg A, Diercke M, Claus H, Hecht J, Eckmanns T, Abu Sin M, Haller S. Kramer R, et al. Among authors: diercke m. Dtsch Arztebl Int. 2020 Nov 20;117(47):809. doi: 10.3238/arztebl.2020.0809. Dtsch Arztebl Int. 2020. PMID: 33549159 Free PMC article. No abstract available.

10

Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1-2016 - week 32-2020.

Ullrich A, Schranz M, Rexroth U, Hamouda O, Schaade L, Diercke M, Boender TS; Robert Koch's Infectious Disease Surveillance Group. Ullrich A, et al. Among authors: diercke m. Lancet Reg Health Eur. 2021 Jun 19;6:100103. doi: 10.1016/j.lanepe.2021.100103. eCollection 2021 Jul. Lancet Reg Health Eur. 2021. PMID: 34557831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page